Transparency Life Sciences, LLC


Overview

Our goal is to develop medicines for significant unmet medical needs by acquiring promising drug compounds, designing studies via crowdsourced methods, and conducting those clinical studies with unmatched productivity. TLS addresses a key barrier to innovation in biotech and pharma today caused by high clinical trials costs. We aim to license or sell compounds we have developed to mid-large pharma.

Management Team

CEO

Tomasz Sablinksi

Harvard, Novartis, Celtic Therapeutics

Chairman, Scientific Advisory Board

Lawrence Steinman

Professor - Stanford, multiple biotechs

COO

Marc Foster

FoldRx, Schrodinger, multiple exits in high tech